Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-26

Clinical Trial Update: Combination of BTL-785F and HPM-6000UF Devices for Women's Intimate Wellness [NA]

View source ↗

Summary

A completed clinical trial evaluating the combination of BTL-785F and HPM-6000UF devices for vulvovaginal atrophy and urinary incontinence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BTL-785F
  • HPM-6000UF

Snippet

Sponsor: BTL Industries Ltd. | Conditions: Vulvovaginal Atrophy, Urinary Incontinence | NA | Status: COMPLETED